Analyst firms · Goldman Sachs · ALEC
Goldman Sachs ALEC price target and rating history
Alector Inc. (ALEC) · Health Care
Goldman Sachs rates Alector Inc. (ALEC) Sell with a $4 price target, as of its latest action on Sep 25, 2023. It has published 3 rating actions on ALEC since August 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Sell
- Price target
- $4
- Median target, all firms
- Too few
- Actions on ALEC
- 3
Goldman Sachs price target on ALEC
Every Goldman Sachs rating on ALEC
- Sep 25, 2023
- Apr 13, 2022
- Aug 3, 2021
How other firms rate ALEC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Overweight | $7 | Nov 13, 2026 |
| Cantor Fitzgerald | Overweight | Apr 15, 2026 | |
| BTIG | Buy | $6 | Mar 10, 2026 |
Questions about Goldman Sachs and ALEC
- What is Goldman Sachs's price target for ALEC?
- Goldman Sachs's latest stated price target for Alector Inc. (ALEC) is $4, from its action on Sep 25, 2023.
- What is Goldman Sachs's rating on ALEC?
- Goldman Sachs rates ALEC Sell, a bearish rating, as of Sep 25, 2023.
- When did Goldman Sachs last change its view on ALEC?
- On Sep 25, 2023, Goldman Sachs starts coverage at Sell, price target $4.
More ALEC rating histories
All Goldman Sachs ratingsALEC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.